Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study

被引：0
|
作者：
Christopher F. Bell
Jake Chung
Bernard Rubin
机构：
[1] GSK,US Value Evidence and Outcomes
[2] GSK,Specialty Care, Global Medical Affairs
[3] GSK,US Medical Affairs, Immuno
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
African American ethnicity; Belimumab; Hispanic ethnicity; Real-world data; Systemic lupus erythematosus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：447 / 462
页数：15
相关论文
共 50 条
  • [11] Correction to: Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study
    Lin, Sishi
    Zhang, Ji
    You, Xiaohan
    Chen, Bo
    Liang, Yan
    Zhou, Yin
    Ding, Xiaokai
    Lv, Yinqiu
    Zhang, Huidi
    Su, Bofeng
    Bai, Yongheng
    Chen, Chaosheng
    RHEUMATOLOGY, 2024,
  • [12] The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study
    Hu, Yinxiu
    Wang, Pengyu
    Cao, Xue
    Wu, Zhenbiao
    Feng, Yuan
    LUPUS, 2025, 34 (02) : 133 - 139
  • [13] Response to belimumab among patients with refractory lupus nephritis: a real-world observational retrospective multicenter study
    Zhang, Shuoyang
    Qiu, Qian
    Zeng, Shan
    Li, Hao
    Xu, Liujing
    Jie, Ligang
    Hu, Xuejun
    Xiao, Youjun
    Chen, Dongying
    Zhan, Zhongping
    Liang, Liuqin
    Yu, Qinghong
    Xu, Hanshi
    CLINICAL RHEUMATOLOGY, 2024, 43 (02) : 837 - 838
  • [14] Real-world effectiveness of intravenous belimumab in adults with systemic lupus erythematosus: results of the observational OBSErve study in the Russian Federation
    Lila, Alexander Mikhailovich
    Aseeva, Elena Aleksandrovna
    Zagrebneva, Alyona Igorevna
    Vinogradova, Irina Borisovna
    Samigullina, Ruzana Ramilovna
    Khamashta, Munther
    Elfishawy, Tamer
    Teichman, Lindsey
    dos Santos, Debora
    Queiroz, Juliana
    Kniazeva, Larisa Alexandrovna
    Noibi, Saeed
    BMC RHEUMATOLOGY, 2025, 9 (01)
  • [15] Response to belimumab among patients with refractory lupus nephritis: a real-world observational retrospective multicenter study
    Shuoyang Zhang
    Qian Qiu
    Shan Zeng
    Hao Li
    Liujing Xu
    Ligang Jie
    Xuejun Hu
    Youjun Xiao
    Dongying Chen
    Zhongping Zhan
    Liuqin Liang
    Qinghong Yu
    Hanshi Xu
    Clinical Rheumatology, 2024, 43 : 199 - 208
  • [16] Real-world efficacy of belimumab in achieving remission or low-disease activity in systemic lupus erythematosus: A retrospective study
    Hasegawa, Yasuhiro
    Arinuma, Yoshiyuki
    Asakura, Hirotomo
    Shindo, Risa
    Ino, Kazuma
    Kanayama, Yoshiro
    Tanaka, Tomoki
    Matsueda, Yu
    Wada, Tatsuhiko
    Oku, Kenji
    Yamaoka, Kunihiro
    MODERN RHEUMATOLOGY, 2023, : 732 - 740
  • [17] Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
    Shirley P. Huang
    Sonya J. Snedecor
    Sakina Nanji
    Emily Lloyd
    Christopher F. Bell
    Rheumatology and Therapy, 2022, 9 : 975 - 991
  • [18] Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
    Huang, Shirley P.
    Snedecor, Sonya J.
    Nanji, Sakina
    Lloyd, Emily
    Bell, Christopher F.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 975 - 991
  • [19] Different pregnancy outcomes in patients with systemic lupus erythematosus treated with belimumab
    Lai, Yupeng
    Li, Bin
    Huang, Jiaming
    Du, Jingning
    Yue, Mengli
    Shen, Xin
    Liu, Xingjiao
    Huang, Lingfeng
    Lin, Jiehua
    Yang, Aicheng
    Wang, Meiying
    LUPUS, 2023, 32 (01) : 149 - 154
  • [20] Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol
    Galindo-Izquierdo, Maria
    Bahamontes-Rosa, Noemi
    Sarto-Ferres, Berta
    Galvez-Fernandez, Marta
    Cortes-Hernandez, Josefina
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
12345